{"id":"cxl","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL4297464","moleculeType":"Small molecule","molecularWeight":"251.28"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CXL works by selectively inhibiting the activity of the enzyme, which is involved in the production of a key inflammatory mediator. This leads to a reduction in inflammation and subsequent tissue damage. By targeting this specific enzyme, CXL aims to provide therapeutic benefits in various inflammatory conditions.","oneSentence":"CXL is a small molecule that inhibits the activity of a specific enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:45:30.537Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe atopic dermatitis"}]},"trialDetails":[{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT04598932","phase":"","title":"Corneal Biomechanical Analysis Using Brillouin Microscopy","status":"ENROLLING_BY_INVITATION","sponsor":"The Cleveland Clinic","startDate":"2021-06-01","conditions":"Keratoconus, Keratoconus, Unstable, Keratoconus, Stable","enrollment":220},{"nctId":"NCT07135167","phase":"PHASE3","title":"Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome","status":"RECRUITING","sponsor":"Woolfson Eye Institute","startDate":"2025-08-01","conditions":"Down Syndrome (DS), Keratoconus, Pellucid Marginal Degeneration","enrollment":225},{"nctId":"NCT07372911","phase":"NA","title":"PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus","status":"RECRUITING","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2025-09-01","conditions":"Keratoconus","enrollment":50},{"nctId":"NCT04439552","phase":"","title":"fMRI and IVCM Cornea Microscopy of CXL in Keratoconus","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-10-04","conditions":"Pain, Postoperative, Pain, Chronic, Pain, Acute","enrollment":60},{"nctId":"NCT06818461","phase":"","title":"Assessment of Corneal Biomechanical Properties Using Corvis ST Following LASIK, PRK, and CXL","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2023-09-01","conditions":"Myopia, Keratoconus, Refractive Surgery","enrollment":150},{"nctId":"NCT07194538","phase":"","title":"One-Year Outcomes After Conventional vs Accelerated Epi-Off Corneal Cross-Linking in Progressive Keratoconus (Observational Cohort)","status":"COMPLETED","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2021-05-09","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT07173907","phase":"","title":"Epi-on CuRV and Epi-off aCXL Protocols in the Management of Keratoconus","status":"COMPLETED","sponsor":"Gemini Eye Clinic","startDate":"2016-01-01","conditions":"Keratoconus","enrollment":135},{"nctId":"NCT03760432","phase":"NA","title":"Collagen Cross-linking in Keratoconus","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2018-06-20","conditions":"Keratoconus","enrollment":100},{"nctId":"NCT07080983","phase":"NA","title":"Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-04-02","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT06967376","phase":"EARLY_PHASE1","title":"The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis","status":"COMPLETED","sponsor":"Research Institute of Ophthalmology, Egypt","startDate":"2018-05-21","conditions":"Infective Keratitis","enrollment":40},{"nctId":"NCT06840990","phase":"","title":"Cross-linked CMC and Silk Proteins in Corneal Re-epithelization","status":"COMPLETED","sponsor":"D&V FARMA srl","startDate":"2023-01-01","conditions":"Corneal Epithelial Wound Healing","enrollment":20},{"nctId":"NCT05457647","phase":"NA","title":"Theranostic Guided Riboflavin/UV-A Corneal Cross-linking","status":"COMPLETED","sponsor":"Regensight","startDate":"2022-04-27","conditions":"Keratoconus","enrollment":50},{"nctId":"NCT04667572","phase":"PHASE1","title":"Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution","status":"COMPLETED","sponsor":"Cornea Associates of Texas","startDate":"2021-02-01","conditions":"Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration","enrollment":249},{"nctId":"NCT04097730","phase":"PHASE3","title":"Steroids and Cross-linking for Ulcer Treatment","status":"COMPLETED","sponsor":"Thomas M. Lietman","startDate":"2020-09-24","conditions":"Keratitis Bacterial","enrollment":280},{"nctId":"NCT04427956","phase":"PHASE4","title":"Corneal Crosslinking Treatment Study","status":"COMPLETED","sponsor":"Region Skane","startDate":"2017-05-23","conditions":"Progressive Keratoconus","enrollment":54},{"nctId":"NCT05870566","phase":"NA","title":"Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]","status":"RECRUITING","sponsor":"Claus Cursiefen","startDate":"2023-11-20","conditions":"Corneal Transplantation","enrollment":110},{"nctId":"NCT06549387","phase":"NA","title":"Topo-Pachymetric Customized Accelerated Epi-On Vs Accelerated Epi-Off Corneal Cross Linking in Keratoconus Management","status":"NOT_YET_RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-08-15","conditions":"Amount of Corneal Flattening (Kmax Flattening), Change in the Endothelial Cell Count","enrollment":55},{"nctId":"NCT06522789","phase":"NA","title":"Preoperative Corneal Measurements Estimate the Corrected Distance Visual Acuity After Corneal Cross-linking","status":"COMPLETED","sponsor":"Sistina Ophthalmology Hospital","startDate":"2018-04-01","conditions":"Keratoconus","enrollment":124},{"nctId":"NCT04532788","phase":"NA","title":"Efficacy of Customized Corneal Cross-linking vs. Standard Corneal Cross-linking","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2021-03-01","conditions":"Keratoconus","enrollment":124},{"nctId":"NCT01604135","phase":"PHASE3","title":"Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sahlgrenska University Hospital","startDate":"2012-05","conditions":"Keratoconus","enrollment":36},{"nctId":"NCT03319082","phase":"","title":"Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery","status":"UNKNOWN","sponsor":"Glaukos Corporation","startDate":"2017-10-04","conditions":"Corneal Ectasia","enrollment":200},{"nctId":"NCT06267495","phase":"","title":"Epithelium-on Cross-linking Versus Observation of Fellow Eyes of Patients With Unilateral Clinically Evident Keratoconus","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-01-01","conditions":"Keratoconus","enrollment":40},{"nctId":"NCT06264024","phase":"NA","title":"Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-02-12","conditions":"Keratoconus","enrollment":81},{"nctId":"NCT06243991","phase":"","title":"The Effect Of High And Low Molecular Weight Sodium Hyaluronic Acid Eye Drops After Crosslinking","status":"COMPLETED","sponsor":"Marmara University","startDate":"2021-03-01","conditions":"Keratoconus","enrollment":63},{"nctId":"NCT04168112","phase":"PHASE4","title":"Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study","status":"COMPLETED","sponsor":"Sight Medical Doctors PLLC","startDate":"2020-02-12","conditions":"Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain","enrollment":20},{"nctId":"NCT03442751","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2018-04-06","conditions":"Progressive Keratoconus","enrollment":201},{"nctId":"NCT03531047","phase":"NA","title":"Refractive Corneal Cross-linking for Progressive Keratoconus","status":"COMPLETED","sponsor":"Moorfields Eye Hospital NHS Foundation Trust","startDate":"2018-11-01","conditions":"Keratoconus","enrollment":53},{"nctId":"NCT05905978","phase":"NA","title":"Donors Predisposed by Corneal Collagen Cross-linking in Deep Lamellar Keratoplasty for the Patients With Keratoconus","status":"NOT_YET_RECRUITING","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2023-06","conditions":"Keratoconus","enrollment":70},{"nctId":"NCT01943643","phase":"NA","title":"Multislice CT Angiography of Coronary Bifurcations and Outcomes After Intervention","status":"COMPLETED","sponsor":"Clinical Hospital Center Zemun","startDate":"2013-09","conditions":"Coronary Artery Disease","enrollment":70},{"nctId":"NCT05691335","phase":"NA","title":"Three Different Cross-linking Protocols for Treatment of Pediatric Keratoconus","status":"COMPLETED","sponsor":"Sohag University","startDate":"2018-06-01","conditions":"Corneal Ectasia","enrollment":97},{"nctId":"NCT05410262","phase":"","title":"Specific Mechanical Power Assessment in Patients With Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Hospital El Cruce","startDate":"2022-07-01","conditions":"Ventilation, Mechanical","enrollment":18},{"nctId":"NCT04811924","phase":"PHASE2","title":"The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients","status":"TERMINATED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2021-07-26","conditions":"Keratoconus","enrollment":4},{"nctId":"NCT01112072","phase":"PHASE3","title":"Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia","status":"UNKNOWN","sponsor":"Cornea and Laser Eye Institute","startDate":"2010-04","conditions":"Keratoconus, Corneal Ectasia","enrollment":160},{"nctId":"NCT05717673","phase":"","title":"Effect of Epi-Off Technique Corneal CXL On Endothelial Count by Specular Microscopy in Keratoconus Patients","status":"UNKNOWN","sponsor":"Heba Allah Nashaat Mohamed","startDate":"2023-01-01","conditions":"Keratoconus, Collagen","enrollment":30},{"nctId":"NCT04383431","phase":"NA","title":"Cross-linking as Treatment in Infectious Keratitis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2020-06-02","conditions":"Infectious Keratitis","enrollment":37},{"nctId":"NCT04897503","phase":"PHASE3","title":"Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose","status":"UNKNOWN","sponsor":"Cornea and Laser Eye Institute","startDate":"2021-04-16","conditions":"Keratoconus, Corneal Ectasia","enrollment":170},{"nctId":"NCT05255107","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":468},{"nctId":"NCT05255016","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":488},{"nctId":"NCT01708538","phase":"PHASE3","title":"The Effects of Corneal Collagen Cross-linking","status":"UNKNOWN","sponsor":"Rush Eye Associates","startDate":"2012-10","conditions":"Corneal Ectasia Disorders Including Keratoconus","enrollment":30},{"nctId":"NCT04177082","phase":"PHASE1","title":"Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution","status":"COMPLETED","sponsor":"Cornea Associates of Texas","startDate":"2020-01-10","conditions":"Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration","enrollment":200},{"nctId":"NCT03220529","phase":"NA","title":"A Study to Test the Potential of Brillouin Microscopy for Biomechanical Properties Measurements in Human Cornea","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2016-11","conditions":"Pellucid Marginal Corneal Degeneration, Keratoconus, Keratectasia","enrollment":85},{"nctId":"NCT01190306","phase":"PHASE3","title":"Safety Study of the VEGA UV-A System to Treat Keratoconus","status":"TERMINATED","sponsor":"Topcon Medical Systems, Inc.","startDate":"2010-08","conditions":"Keratoconus","enrollment":127},{"nctId":"NCT01398839","phase":"PHASE3","title":"Safety Study of the VEGA UV-A System to Treat Ectasia","status":"TERMINATED","sponsor":"Topcon Medical Systems, Inc.","startDate":"2010-12","conditions":"Ectasia","enrollment":103},{"nctId":"NCT01398852","phase":"PHASE3","title":"Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia","status":"TERMINATED","sponsor":"Topcon Medical Systems, Inc.","startDate":"2010-12","conditions":"Keratoconus and Ectasia","enrollment":500},{"nctId":"NCT05176171","phase":"NA","title":"Surface Ablation With Corneal Cross Linking in Mild Keratoconus","status":"UNKNOWN","sponsor":"Shahid Beheshti University","startDate":"2018-03-05","conditions":"Keratoconus, Corneal Cross-Linking","enrollment":50},{"nctId":"NCT03890718","phase":"NA","title":"Topography Versus Non-Topography-Guided PRK With CXL in Keratoconus","status":"UNKNOWN","sponsor":"Shahid Beheshti University","startDate":"2017-03-30","conditions":"Keratoconus","enrollment":38},{"nctId":"NCT03029104","phase":"PHASE2","title":"Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas","status":"TERMINATED","sponsor":"Cxlusa","startDate":"2016-12-21","conditions":"Keratoconus, Corneal Diseases, Eye Diseases","enrollment":2228},{"nctId":"NCT05161052","phase":"NA","title":"Assessment of Corneal Stiffness in Keratoconus After Crosslinking by Corvis ST and OCT.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-01-01","conditions":"Keratoconus","enrollment":55},{"nctId":"NCT05136924","phase":"PHASE2","title":"IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL","status":"UNKNOWN","sponsor":"Vance Thompson Vision - MT","startDate":"2021-12-01","conditions":"Dry Eye Disease","enrollment":20},{"nctId":"NCT05114928","phase":"","title":"Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.","status":"COMPLETED","sponsor":"Benha University","startDate":"2021-10-09","conditions":"Keratoconus, Collagen Diseases, Corneal Disease","enrollment":9},{"nctId":"NCT05019768","phase":"NA","title":"Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS","status":"COMPLETED","sponsor":"Ciro Caruso","startDate":"2017-09-01","conditions":"Keratoconus","enrollment":41},{"nctId":"NCT03801590","phase":"NA","title":"Crosslinking in Infectious Keratitis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-12-01","conditions":"Infectious Keratitis","enrollment":20},{"nctId":"NCT04731727","phase":"EARLY_PHASE1","title":"Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)","status":"NOT_YET_RECRUITING","sponsor":"Kent Wellish MD","startDate":"2021-06-30","conditions":"Keratoconus, Unstable","enrollment":600},{"nctId":"NCT00674661","phase":"PHASE3","title":"Corneal Collagen Cross-Linking for Ectasia (CXL)","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2007-12","conditions":"Ectasia","enrollment":130},{"nctId":"NCT00647699","phase":"PHASE3","title":"Corneal Collagen Cross-linking for Progressive Keratoconus","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2007-12","conditions":"Progressive Keratoconus","enrollment":147},{"nctId":"NCT04820608","phase":"NA","title":"Transepithelial Customized Cross-linking","status":"UNKNOWN","sponsor":"Ophthalmica Eye Institute","startDate":"2018-02-01","conditions":"Keratoconus","enrollment":50},{"nctId":"NCT04464083","phase":"","title":"IOP Measurements Using ORA After ACXL in Keratoconus","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2020-04-12","conditions":"IOP Readings Before and After Accelerated Corneal Collagen Crosslinking (CXL)","enrollment":20},{"nctId":"NCT02425150","phase":"NA","title":"Treatment of Keratoconus With Advanced Corneal Crosslinking","status":"COMPLETED","sponsor":"Umeå University","startDate":"2009-10","conditions":"Keratoconus","enrollment":120},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT04504578","phase":"NA","title":"Efficacy and Safety ofCACXL in the Treatment of Keratoconus With Thin Corneas","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2018-01-01","conditions":"Progressive Keratoconus","enrollment":30},{"nctId":"NCT04405882","phase":"","title":"Cornea Ectasia Excimer Laser Treatment","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2019-10-01","conditions":"Corneal Ectasia","enrollment":8},{"nctId":"NCT04343326","phase":"PHASE2, PHASE3","title":"The Additional Role of Supplemental Oxygen Therapy in Accelerated Corneal Collagen Cross-linking in Progressive Keratoconus. A Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2020-01-01","conditions":"Keratoconus","enrollment":30},{"nctId":"NCT03245853","phase":"PHASE4","title":"Epi-On Corneal Crosslinking for Keratoconus","status":"COMPLETED","sponsor":"Comprehensive EyeCare of Central Ohio","startDate":"2017-07-18","conditions":"Keratoconus, Keratoconus, Unstable","enrollment":20},{"nctId":"NCT04160338","phase":"","title":"Assessment of Corneal Endothelium After Collagen Cross Linking","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-12","conditions":"Accelerated Corneal Collagen Cross Linking","enrollment":25},{"nctId":"NCT02872766","phase":"NA","title":"Evaluation of the Safety and Efficacy of Corneal Cross Linking for the Treatment of Myopia.","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2016-01","conditions":"Myopia","enrollment":24},{"nctId":"NCT01868620","phase":"NA","title":"Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus.","status":"TERMINATED","sponsor":"University Hospital, Toulouse","startDate":"2013-05","conditions":"Progressive Keratoconus","enrollment":28},{"nctId":"NCT03879421","phase":"NA","title":"Evaluation of the Keratoconic Cornea After Corneal Collagen Cross Linking.","status":"UNKNOWN","sponsor":"Reham Mahmoud Abdelrahman","startDate":"2016-10-01","conditions":"Keratoconus","enrollment":44},{"nctId":"NCT03858036","phase":"PHASE3","title":"Corneal Collagen Cross-Linking (CXL) Performed With \"Epi-ON\" Versus \"Epi-OFF\" in Eyes With Keratoconus and Other Corneal Ectatic Disorders","status":"UNKNOWN","sponsor":"Center for Sight, Sacramento, CA","startDate":"2019-03-08","conditions":"Keratoconus, Ectasia","enrollment":550},{"nctId":"NCT03295292","phase":"PHASE1","title":"Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2017-08-01","conditions":"Corneal Scars and Opacities","enrollment":15},{"nctId":"NCT02208089","phase":"NA","title":"Simultaneous TransPRK and Corneal Collagen Cross-Linking","status":"COMPLETED","sponsor":"Bruce Allan","startDate":"2014-08","conditions":"Keratoconus","enrollment":55},{"nctId":"NCT03791684","phase":"NA","title":"Accelerated Versus Standard CXL in the Treatment of Ectasia Post Refractive Surgery and Penetrating Keratoplasty.","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2016-01-16","conditions":"Refractive Surgery","enrollment":111},{"nctId":"NCT03753009","phase":"","title":"Iontophoretic Transepithelial Collagen Cross-linking Versus Epithelium-off Collagen Cross-linking in Pediatric Patients. Three Year Follow up.","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2013-01-01","conditions":"Keratoconus","enrollment":28},{"nctId":"NCT01956474","phase":"PHASE2","title":"CXL-04 A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas","status":"TERMINATED","sponsor":"Cxlusa","startDate":"2013-01","conditions":"Keratoconus","enrollment":1324},{"nctId":"NCT01189864","phase":"","title":"Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas","status":"TERMINATED","sponsor":"Cxlusa","startDate":"2010-02-01","conditions":"Keratoconus, Ectasia, Degeneration","enrollment":3493},{"nctId":"NCT01672814","phase":"PHASE3","title":"Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus","status":"COMPLETED","sponsor":"Cornea and Laser Eye Institute","startDate":"2012-08","conditions":"Keratoconus","enrollment":3},{"nctId":"NCT03080077","phase":"PHASE3","title":"Safety and Effectiveness of Corneal Crosslinking (CXL): Keratoconus and Post-Refractive Ectasia","status":"UNKNOWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2016-06","conditions":"Keratoconus, Ectasia","enrollment":8},{"nctId":"NCT02514200","phase":"PHASE2","title":"Treatment of Keratoconus With Advanced CXL-II","status":"UNKNOWN","sponsor":"Umeå University","startDate":"2014-03","conditions":"Keratoconus","enrollment":50},{"nctId":"NCT03355430","phase":"","title":"Simultaneous Corneal Wavefront-Guided Trans-PRK and Corneal Collagen Crosslinking After ICRS Implantation for Moderate Keratoconus","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-07-07","conditions":"Moderate Keratoconus","enrollment":23},{"nctId":"NCT01789528","phase":"PHASE1","title":"A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-08","conditions":"Pharmacokinetics, Open Label, CAZ-AVI","enrollment":48},{"nctId":"NCT02088970","phase":"NA","title":"Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)","status":"TERMINATED","sponsor":"Nantes University Hospital","startDate":"2014-09","conditions":"Bacterial Keratitis, Fungal Keratitis","enrollment":21},{"nctId":"NCT03138785","phase":"NA","title":"UVX as an Adjuvant in the Treatment of Fungal Keratitis","status":"UNKNOWN","sponsor":"Farabi Eye Hospital","startDate":"2015-01-01","conditions":"Treatment","enrollment":20},{"nctId":"NCT01624246","phase":"PHASE1","title":"Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-05","conditions":"Augmented Renal Clearance (ARC), Systemic Inflammatory Response Syndrome (SIRS)","enrollment":12},{"nctId":"NCT01471873","phase":"","title":"Variability of Pentacam-derived Back Elevation Measurements in Keratoconus and Cross-linked Corneas","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2011-03","conditions":"Keratoconus","enrollment":67},{"nctId":"NCT01845714","phase":"NA","title":"Impact of Keratoconus, Cross-linking and Cross-linking Combined With Topo-guided Photorefractive Keratectomy on Self-reported Quality of Life. A Three-year Update.","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2009-04","conditions":"Keratoconus","enrollment":28},{"nctId":"NCT01527721","phase":"NA","title":"Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2010-09","conditions":"Keratoconus","enrollment":32},{"nctId":"NCT02943967","phase":"NA","title":"Corneal Cross-linking and Refractive Surface Ablation in Patients With Asymmetric Corneas","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2010-01","conditions":"Surgical Procedure, Unspecified","enrollment":44},{"nctId":"NCT02883868","phase":"","title":"Stromal Demarcation Line: is it Predictive for Cross-Linking Efficiency?","status":"COMPLETED","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2015-10","conditions":"Progressive Keratoconus","enrollment":36},{"nctId":"NCT02883478","phase":"PHASE1, PHASE2","title":"Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2012-08","conditions":"Keratoconus, Corneal Ectasia","enrollment":40},{"nctId":"NCT02867176","phase":"PHASE4","title":"Pain Management in Corneal Collagen Crosslinking for Keratoconus","status":"COMPLETED","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2016-01","conditions":"Pain","enrollment":25},{"nctId":"NCT02009709","phase":"PHASE1","title":"Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2","status":"UNKNOWN","sponsor":"Robert Mack, M.D.","startDate":"2013-10","conditions":"Keratoconus, Corneal Ectasia","enrollment":100},{"nctId":"NCT01726283","phase":"","title":"Combined CXL//UV and PRK or LASIK in Forme Fruste Keratoconus or Eyes With Potential Risk of Ectasia","status":"COMPLETED","sponsor":"Cxlusa","startDate":"2011-10","conditions":"Fruste Keratoconus, Risk of Ectasia","enrollment":22},{"nctId":"NCT02456961","phase":"NA","title":"Standard Corneal Collagen Crosslinking Versus Transepithelial Corneal Crosslinking by Iontophoresis of Riboflavin","status":"COMPLETED","sponsor":"Ufa Eye Research Institute","startDate":"2010-01","conditions":"Keratoconus","enrollment":126},{"nctId":"NCT02349165","phase":"NA","title":"Standard Versus Transepithelial Corneal Crosslinking","status":"COMPLETED","sponsor":"Nienke Soeters","startDate":"2011-05","conditions":"Keratoconus","enrollment":61},{"nctId":"NCT02328053","phase":"NA","title":"Clinical & Visual Outcomes of Collagen Cross Linking for Fungal Keratitis","status":"UNKNOWN","sponsor":"Aravind Eye Care System","startDate":"2014-02","conditions":"Mycotic Corneal Ulcer","enrollment":20},{"nctId":"NCT01181219","phase":"PHASE2","title":"Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of Keratoconus","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2010-07","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT01281462","phase":"PHASE2","title":"Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2010-12","conditions":"Urinary Tract Infections","enrollment":217},{"nctId":"NCT02008175","phase":"NA","title":"Conventional Collagen Crosslinking in Young Keratoconus","status":"COMPLETED","sponsor":"Vasan Eye Care Hospital","startDate":"2012-01","conditions":"Keratoconus","enrollment":21},{"nctId":"NCT01411384","phase":"NA","title":"Evaluation of Corneal Hysteresis and Corneal Resistance Factor After Corneal Cross-linking for Keratoconus","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2008-04","conditions":"Progressive Keratoconus","enrollment":80},{"nctId":"NCT01527708","phase":"","title":"Accuracy of Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Post-CXL Corneas","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2011-09","conditions":"Keratoconus","enrollment":129}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2118,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cohort 2"],"phase":"phase_3","status":"active","brandName":"CXL","genericName":"CXL","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CXL is a small molecule that inhibits the activity of a specific enzyme. Used for Moderate to severe atopic dermatitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}